| Allan Richard Au, MD | |
|
9727 Elk Grove Florin Rd Ste 180, Elk Grove, CA 95624-2267 | |
| (916) 686-8170 | |
| (916) 685-8195 |
| Full Name | Allan Richard Au |
|---|---|
| Gender | Male |
| Speciality | Allergy & Immunology |
| Location | 9727 Elk Grove Florin Rd Ste 180, Elk Grove, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780636761 | NPI | - | NPPES |
| G76867 | Other | CA | BLUE CROSS |
| 00G768670 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | G76867 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Allan Richard Au, MD 9727 Elk Grove Florin Rd Ste 180, Elk Grove, CA 95624-2267 Ph: (916) 686-8170 | Allan Richard Au, MD 9727 Elk Grove Florin Rd Ste 180, Elk Grove, CA 95624-2267 Ph: (916) 686-8170 |
News Archive
UK scientists have developed a new blood test that can diagnose cases of variant Creutzfeldt-Jakob Disease (vCJD), a rare, fatal brain disease caused by proteins known as prions. These prions are also responsible for the mad cow disease, or bovine spongiform encephalopathy (BSE). This test could in near future be used to identify contaminated blood and prevent transmission of the disease during blood transfusions, the researchers said.
Patients with gynecologic cancer have new hope in a novel technology now offered at the Seidman Cancer Center at University Hospitals (UH) Case Medical Center. A team of cancer specialists, led by Robert DeBernardo, MD, is among the first in the nation to launch a dedicated program using Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat ovarian, endometrial and select other cancers.
New research has identified the mechanisms that trigger disruption in the brain's communication channels linked to symptoms in psychiatric disorders including schizophrenia. The University of Bristol study, published today [17 Aug] in the Proceedings of National Academy of Sciences, could have important implications for treating symptoms of brain disorders.
Researchers from The Methodist Hospital's DeBakey Heart and Vascular Center in Houston, Texas have studied outcomes of patients who had endovascular and open interventions for recurrent superficial femoral artery (SFA) occlusive disease. Results of their work are detailed in the August issue of the Society for Vascular Surgery's® Journal of Vascular Surgery®.
› Verified 6 days ago
Dr. Mark I Grijnsztein, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 8170 Laguna Blvd, Suite 200, Elk Grove, CA 95758 Phone: 916-478-6555 |